John E Kerrigan - JoVE Visualize

Showing results (11-20 of 32) with videos related to

Pageof 4

Sort By:

Endocrine|July 22, 2005

Models of glycoprotein hormone receptor interactionWilliam R Moyle, Win Lin, Rebecca V Myers, et al.

Oncology Research|January 26, 2005

Design and construction of a phosphorylatable chimeric monoclonal antibody with a highly stable phosphateWei Wu, John E Kerrigan, Prem Yadav, et al.

Molecular and Cellular Endocrinology|October 25, 2006

Follitropin receptors contain cryptic ligand binding sitesWin Lin, Michael P Bernard, Donghui Cao, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2016

NAD+ Kinase as a Therapeutic Target in CancerPhilip M Tedeschi, Nitu Bansal, John E Kerrigan, et al.

Bioorganic & Medicinal Chemistry Letters|September 25, 2003

5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones and related compounds as TOP1-targeting agents: influence of structure on the ternary cleavable complex formationJohn E Kerrigan, Daniel S Pilch, Alexander L Ruchelman, et al.

The Journal of Biological Chemistry|August 12, 2004

Model of glycoprotein hormone receptor ligand binding and signalingWilliam R Moyle, Yongna Xing, Win Lin, et al.

Molecular Pharmacology|July 30, 2015

Suppression of Cytosolic NADPH Pool by Thionicotinamide Increases Oxidative Stress and Synergizes with ChemotherapyPhilip M Tedeschi, HongXia Lin, Murugesan Gounder, et al.

Cell Reports|April 14, 2015

Identification of a Non-Gatekeeper Hot Spot for Drug-Resistant Mutations in mTOR KinaseTzung-Ju Wu, Xiaowen Wang, Yanjie Zhang, et al.

Experimental Cell Research|January 31, 2017

Tumor stroma interaction is mediated by monocarboxylate metabolismBrijesh B Patel, Ellen Ackerstaff, Inna S Serganova, et al.

Bioorganic & Medicinal Chemistry|June 10, 2004

Nitro and amino substitution within the A-ring of 5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: influence on topoisomerase I-targeting activity and cytotoxicityAlexander L Ruchelman, John E Kerrigan, Tsai-Kun Li, et al.

Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:

Pageof 4

Endocrine|July 22, 2005

Models of glycoprotein hormone receptor interactionWilliam R Moyle, Win Lin, Rebecca V Myers, et al.

Oncology Research|January 26, 2005

Design and construction of a phosphorylatable chimeric monoclonal antibody with a highly stable phosphateWei Wu, John E Kerrigan, Prem Yadav, et al.

Molecular and Cellular Endocrinology|October 25, 2006

Follitropin receptors contain cryptic ligand binding sitesWin Lin, Michael P Bernard, Donghui Cao, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2016

NAD+ Kinase as a Therapeutic Target in CancerPhilip M Tedeschi, Nitu Bansal, John E Kerrigan, et al.

Bioorganic & Medicinal Chemistry Letters|September 25, 2003

5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones and related compounds as TOP1-targeting agents: influence of structure on the ternary cleavable complex formationJohn E Kerrigan, Daniel S Pilch, Alexander L Ruchelman, et al.

The Journal of Biological Chemistry|August 12, 2004

Model of glycoprotein hormone receptor ligand binding and signalingWilliam R Moyle, Yongna Xing, Win Lin, et al.

Molecular Pharmacology|July 30, 2015

Suppression of Cytosolic NADPH Pool by Thionicotinamide Increases Oxidative Stress and Synergizes with ChemotherapyPhilip M Tedeschi, HongXia Lin, Murugesan Gounder, et al.

Cell Reports|April 14, 2015

Identification of a Non-Gatekeeper Hot Spot for Drug-Resistant Mutations in mTOR KinaseTzung-Ju Wu, Xiaowen Wang, Yanjie Zhang, et al.

Experimental Cell Research|January 31, 2017

Tumor stroma interaction is mediated by monocarboxylate metabolismBrijesh B Patel, Ellen Ackerstaff, Inna S Serganova, et al.

Bioorganic & Medicinal Chemistry|June 10, 2004

Nitro and amino substitution within the A-ring of 5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: influence on topoisomerase I-targeting activity and cytotoxicityAlexander L Ruchelman, John E Kerrigan, Tsai-Kun Li, et al.

Pageof 4